Inherited Mutations in 18 Percent With Ovarian Cancer
Mutations seen in BRCA1/2, DNA mismatch repair genes, other suspected/established risk genes
ASCO: CTC Heterogeneity Predicts Hormone Tx Response in mCRPC
Patients with higher heterogeneity score did not respond well to hormone therapy
Considerable Subclinical Cardiac Disease in Childhood CA Survivors
Exposure to anthracycline and heart radiation tied to higher odds
Many Patients Using E-Mail As First Method of Provider Contact
Online communications reduced need for phone calls and office visits for many
ASCO: Aspirin Use Linked to Lower Risk of Lethal Prostate CA
Risk of prostate cancer mortality reduced with regular aspirin use after diagnosis
Researchers Calculate Family Risk Estimates for Cancer
Estimated 33 percent of overall risk is genetic; certain types of cancer have additional risk
Axillary pCR Linked to Improved Breast Cancer Survival
Very high survival for axillary pathologic complete response for women with HER2-positive disease
ASCO: Cabozantinib Improves Progression-Free Survival in RCC
Improvements seen across patient subgroups defined by risk category, tumor burden, prior therapy
Diagnostic Factors May Help Patients Avoid Prostate Biopsy
Prostate-specific antigen density, total tumor length are significant predictors
β-Genus Human Papillomavirus Poses Skin Cancer Risk
HPV subtypes 5, 8, 17, 20, and 38 tied to significant increased risk
